These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Electrically evoked compound action potential thresholds of pediatric cochlear implant recipients and its clinical application].
    Author: Xi X, Hong MD, Han DY, Huang DL, Yang WY.
    Journal: Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):43-6. PubMed ID: 12778767.
    Abstract:
    OBJECTIVE: To investigate the possibility of using pediatric cochlear implant mapping protocol, to estimate the psychophysical levels based on the electrically evoked compound action potential (ECAP) threshold measured with the neural response telemetry (NRT) capabilities of cochlear corporation's CI24M device. METHODS: ECAP amplitude growth functions were regressed via NRT 3.0 software to determine ECAP threshold. 6 pediatric cochlear implant recipients' ECAP thresholds 1, 2 and 3 months after surgery were compared, meanwhile, intraoperative and postoperative ECAP thresholds in 7 pediatric recipients were compared. RESULTS: The ECAP amplitude growth functions were not linear when ECAP was close to threshold or saturation. There were no significant difference among the ECAP thresholds 1, 2 and 3 months after surgery. The average intraoperative ECAP threshold of 22 electrodes was 15 CL greater than postoperative threshold. It showed high relationship between them (R2 = 0.9154). CONCLUSION: ECAP threshold should be determined by regression of data from linear part of amplitude growth function. Only one NRT trial should be assessed when mapping protocol based on ECAP threshold to estimate pediatric map parameter. The intraoperative ECAP threshold can act as C-level at the initial mapping. Key words cochlear implant, electrically evoked compound action potential, mapping.
    [Abstract] [Full Text] [Related] [New Search]